• OPEN AN ACCOUNT
Indian Indices
Sensex
72,472.33 879.09
( 1.23%)
Global Indices
Nasdaq
51,671.07 418.43
(0.82%)
Dow Jones
7,831.57 45.21
(0.58%)
Hang Seng
69,084.74 42.63
(0.06%)
Nikkei 225
10,559.70 118.10
(1.13%)
Forex
USD-INR
96.78 0.11
(0.12%)
EUR-INR
108.39 0.07
(0.07%)
GBP-INR
127.86 0.00
(0.00%)
JPY-INR
0.61 0.00
(0.21%)

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
78788
INE0O5T01011
276.4035981
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
REMUS
46.56
1150.53
EPS(TTM)
Face Value()
Div & Yield %
20.97
10
0.05
 

Indo Count Industries consolidated net profit rises 14.96% in the March 2026 quarter
Jun 01,2026
Net profit of Indo Count Industries rose 14.96% to Rs 24.20 crore in the quarter ended March 2026 as against Rs 21.05 crore during the previous quarter ended March 2025. Sales rose 3.43% to Rs 1057.68 crore in the quarter ended March 2026 as against Rs 1022.56 crore during the previous quarter ended March 2025.

For the full year,net profit declined 49.33% to Rs 126.68 crore in the year ended March 2026 as against Rs 250.00 crore during the previous year ended March 2025. Sales declined 0.24% to Rs 4141.35 crore in the year ended March 2026 as against Rs 4151.39 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales1057.681022.56 3 4141.354151.39 0
OPM %8.168.78 -9.4612.94 -
PBDT72.7659.60 22 325.43453.58 -28
PBT30.1625.54 18 166.25337.65 -51
NP24.2021.05 15 126.68250.00 -49